{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Pneumococcal+Vaccine&page=2", "query": { "condition": "Pneumococcal Vaccine", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Pneumococcal+Vaccine&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T09:25:29.310Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03207750", "title": "This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rotavirus Infection", "Rotavirus Vaccines" ], "interventions": [ { "name": "Rotarix", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Prevenar 13", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 1280, "start_date": "2017-09-14", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2020-12-29", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 40 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Daly City", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207750" }, { "nct_id": "NCT03615482", "title": "A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infections" ], "interventions": [ { "name": "V114", "type": "BIOLOGICAL" }, { "name": "QIV", "type": "BIOLOGICAL" }, { "name": "Matching Placebo for V114", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 1200, "start_date": "2018-09-14", "completion_date": "2019-06-24", "has_results": true, "last_update_posted_date": "2024-05-22", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 45, "location_summary": "Birmingham, Alabama • Chandler, Arizona • Mesa, Arizona + 39 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03615482" }, { "nct_id": "NCT07071909", "title": "Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Malignancy", "Cancer", "Hematological Malignancies", "Lymphoma", "Leukemia", "Multiple Myeloma", "Solid Tumor" ], "interventions": [ { "name": "Commercial CAR-T", "type": "BIOLOGICAL" }, { "name": "Investigational CAR-T", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 0, "start_date": "2025-01-20", "completion_date": "2025-08-29", "has_results": false, "last_update_posted_date": "2026-01-06", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07071909" }, { "nct_id": "NCT06049134", "title": "Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "PCV20", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2023-10-06", "completion_date": "2027-12-01", "has_results": false, "last_update_posted_date": "2026-03-09", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06049134" }, { "nct_id": "NCT06824194", "title": "Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Immunization" ], "interventions": [ { "name": "PCV21 vaccine", "type": "BIOLOGICAL" }, { "name": "Prevnar 20 vaccine", "type": "BIOLOGICAL" }, { "name": "M-M-R II vaccine", "type": "BIOLOGICAL" }, { "name": "Rotarix", "type": "BIOLOGICAL" }, { "name": "RotaTeq", "type": "BIOLOGICAL" }, { "name": "Vaxelis vaccine", "type": "BIOLOGICAL" }, { "name": "Varivax", "type": "BIOLOGICAL" }, { "name": "Priorix", "type": "BIOLOGICAL" }, { "name": "VAQTA", "type": "BIOLOGICAL" }, { "name": "Havrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2360, "start_date": "2025-02-18", "completion_date": "2027-10-22", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 103, "location_summary": "Birmingham, Alabama • Guntersville, Alabama • Oneonta, Alabama + 81 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Guntersville", "state": "Alabama" }, { "city": "Oneonta", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06824194" }, { "nct_id": "NCT03803202", "title": "A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pneumonia, Bacterial", "Healthy Volunteers", "Pneumococcal Disease" ], "interventions": [ { "name": "ASP3772", "type": "BIOLOGICAL" }, { "name": "PCV13", "type": "BIOLOGICAL" }, { "name": "PPSV23", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 630, "start_date": "2019-01-24", "completion_date": "2020-09-28", "has_results": true, "last_update_posted_date": "2023-12-21", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 26, "location_summary": "Banning, California • San Diego, California • San Marcos, California + 21 more", "locations": [ { "city": "Banning", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Marcos", "state": "California" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Savannah", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03803202" }, { "nct_id": "NCT00824850", "title": "Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumococcal Conjugate Vaccine" ], "interventions": [ { "name": "13-valent Pneumococcal Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "8 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "8 Years to 16 Years" }, "enrollment_count": 75, "start_date": "2010-01", "completion_date": "2010-09", "has_results": true, "last_update_posted_date": "2011-11-11", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 2, "location_summary": "Hayward, California • San Jose, California", "locations": [ { "city": "Hayward", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00824850" }, { "nct_id": "NCT00384397", "title": "A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Meningitis", "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "249 Days", "maximum_age": "305 Days", "sex": "ALL", "summary": "249 Days to 305 Days" }, "enrollment_count": 1128, "start_date": "2006-09", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 39, "location_summary": "Montgomery, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 35 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00384397" }, { "nct_id": "NCT07348692", "title": "Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Immunization", "Healthy Volunteers" ], "interventions": [ { "name": "PCV21 vaccine", "type": "BIOLOGICAL" }, { "name": "20vPCV licensed vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 2195, "start_date": "2026-01-20", "completion_date": "2028-05-29", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 13, "location_summary": "Fayetteville, Arkansas • Huntington Park, California • Los Angeles, California + 9 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Huntington Park", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07348692" }, { "nct_id": "NCT05420961", "title": "A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumonia, Pneumococcal" ], "interventions": [ { "name": "V116", "type": "BIOLOGICAL" }, { "name": "PCV15", "type": "BIOLOGICAL" }, { "name": "PPSV23", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 717, "start_date": "2022-07-12", "completion_date": "2023-05-16", "has_results": true, "last_update_posted_date": "2024-10-26", "last_synced_at": "2026-06-10T09:25:29.310Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Tempe, Arizona + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05420961" } ] }